Affiliations 

  • 1 From the aDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC; bSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan; cCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Pok Fu Lam, Hong Kong; dSchool of Pharmacy, Monash University Malaysia, Selangor, Malaysia; eCenter for Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; fSchool of Pharmacy, University of Wisconsin, Madison, WI; gSchool of Population Health, University of Queensland, Brisbane, QLD, Australia; hGraduate Institute of Clinical Medicine Science, China Medical University, Taichung, Taiwan; iDepartment of Pharmacoepidemiology, University of Tokyo, Tokyo, Japan; jDepartment of Epidemiology, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore, Singapore; kDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea; lOffice of Drug Utilization Review, Korea Institute of Drug Safety and Risk Management, Seoul, South Korea; mQuality Use of Medicines and Pharmacy Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia; nPharmacy Practice, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand; and oInstitute of Hospital Management, West China Hospital, Sichuan University, Sichuan, People's Republic of China
Epidemiology, 2015 Nov;26(6):815-20.
PMID: 26133022 DOI: 10.1097/EDE.0000000000000325

Abstract

This study describes the availability and characteristics of databases in Asian-Pacific countries and assesses the feasibility of a distributed network approach in the region.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.